US2003166517A1PendingUtilityA1
Galenical formulations
Priority: May 27, 1993Filed: Mar 12, 2003Published: Sep 4, 2003
Est. expiryMay 27, 2013(expired)· nominal 20-yr term from priority
A61K 9/1075A61K 31/70A61P 37/06A61P 37/00A61K 9/4858A61K 47/10A61K 31/436A61K 47/44A61P 37/02
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A pharmaceutical composition containing macrolide, e.g. a rapamycin compound in an emulsion preconcentrate or microemulsion preconcentrate for oral administration. The carrier medium for the rapamycin compound includes a hydrophilic phase, a lipophilic phase and a surfactant. The composition is stable and provides high absorption efficiency.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical composition comprising a macrolide and a carrier medium comprising a hydrophilic phase, a lipophilic phase and a surfactant.
2 . A composition according to claim 1 in the form of an emulsion or a microemulsion preconcentrate.
3 . A composition according to claim 1 or claim 2 in which the lipophilic phase comprises 10 to 85% by weight of the carrier medium.
4 . A composition according to any one of claims 1 to 3 in which the surfactant comprises 5 to 80% by weight of the carrier medium.
5 . A composition according to any one of claims 1 to 4 in which the hydrophilic phase comprises 10 to 50% by weight of the carrier medium.
6 . A composition according to any one of claims 1 to 5 in which the compound of the rapamycin class is present in an amount of 2 to 15% by weight of the composition.
7 . A composition according to any one of claims 1 to 6 in which the macrolide is a compound of the rapamycin class.
8 . A composition according to any one of claims 1 to 6 in which the macrolide is a FK 506 compound.
9 . An microemulsion preconcentrate carrier medium for an orally administrable active agent other than a cyclosporin which comprises
i) a reaction product of a castor oil and ethylene oxide, ii) a transesterification product of a vegetable oil and glycerol comprising predominantly linoleic acid or oleic acid, mono-, di- and triglycerides or a polyoxyalkylated vegetable oil, iii) 1,2 propylene glycol and iv) ethanol.Join the waitlist — get patent alerts
Track US2003166517A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.